Sort   by:  
 Page size 
Genomicsena-DATASET-IGR-28-10-2016-14:22:46:181-287 - samples
Whole-exome sequencing (WES) of 216 breast cancer metastasis-normal pairs from patients who underwent a biopsy in the context of the SAFIR01, SAFIR02, SHIVA or MOSCATO prospective trials (France).
EGAD00001002747 | EGA
GenomicsWhole-exome sequencing of breast cancer metastasis and corresponding blood samples
This study included samples from metastatic breast cancer patients who underwent a biopsy in the context of SAFIR01 (NCT01414933), SAFIR02 (NCT02299999), SHIVA (NCT01771458) and MOSCATO (NCT01566019) prospective trials. These French multicentre trials used high throughput genome analysis on fresh fr...
EGAS00001001695 | EGA
GenomicsData Access Committee for the Metastatic Breast Cancer Whole-exome sequencing study
Data Access Committee EGAC00001000434
EGAC00001000434 | EGA
TranscriptomicsSAFIR01_FabriceAndre_AGILENT_CGH
Breast cancer includes a large number of genomic segments defined by targetable genomic alterations. This multicentre molecular screening program aims to identify these abnormalities in individual patients in order to propose a targeted therapy matched to the genomic alteration.
ORGANISM(S): Homo sapiens 
2013-04-11 | E-MTAB-2076 | biostudies-arrayexpress
Sort   by:  
 Page size